79 related articles for article (PubMed ID: 11606076)
1. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells.
Wobus M; Kuns R; Wolf C; Horn LC; Köhler U; Sheyn I; Werness BA; Sherman LS
Gynecol Oncol; 2001 Nov; 83(2):227-34. PubMed ID: 11606076
[TBL] [Abstract][Full Text] [Related]
2. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
Yoon SO; Shin S; Lipscomb EA
Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
6. Synergy of epidermal growth factor receptor kinase inhibitor AG1478 and ErbB2 kinase inhibitor AG879 in human colon carcinoma cells is associated with induction of apoptosis.
Zhou Y; Brattain MG
Cancer Res; 2005 Jul; 65(13):5848-56. PubMed ID: 15994962
[TBL] [Abstract][Full Text] [Related]
7. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
[TBL] [Abstract][Full Text] [Related]
8. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
Chen X; Yeung TK; Wang Z
Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
[TBL] [Abstract][Full Text] [Related]
9. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
11. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
Pagano E; Calvo JC
J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
13. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
Contessa JN; Abell A; Valerie K; Lin PS; Schmidt-Ullrich RK
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):851-8. PubMed ID: 16751066
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
15. Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells.
Jannot CB; Beerli RR; Mason S; Gullick WJ; Hynes NE
Oncogene; 1996 Jul; 13(2):275-82. PubMed ID: 8710366
[TBL] [Abstract][Full Text] [Related]
16. Prolonged EGFR signaling by ERBB2-mediated sequestration at the plasma membrane.
Offterdinger M; Bastiaens PI
Traffic; 2008 Jan; 9(1):147-55. PubMed ID: 17956594
[TBL] [Abstract][Full Text] [Related]
17. CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells.
Wobus M; Rangwala R; Sheyn I; Hennigan R; Coila B; Lower EE; Yassin RS; Sherman LS
Appl Immunohistochem Mol Morphol; 2002 Mar; 10(1):34-9. PubMed ID: 11893033
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs): simple drugs with a complex mechanism of action?
Normanno N; Maiello MR; De Luca A
J Cell Physiol; 2003 Jan; 194(1):13-9. PubMed ID: 12447985
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of type I growth factor receptors in pterygium.
Liu Z; Xie Y; Zhang M
Chin Med J (Engl); 2002 Mar; 115(3):418-21. PubMed ID: 11940379
[TBL] [Abstract][Full Text] [Related]
20. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
